Cargando…
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
AIM: Pemetrexed, a new generation antifolate drug, has been approved for the treatment of locally advanced or metastatic breast cancer. However, factors affecting its efficacy and resistance have not been fully elucidated yet. ATP-binding cassette (ABC) transporters are predictors of prognosis as we...
Autores principales: | Chen, Jihui, Wang, Zhipeng, Gao, Shouhong, Wu, Kejin, Bai, Fang, Zhang, Qiqiang, Wang, Hongyu, Ye, Qin, Xu, Fengjing, Sun, Hong, Lu, Yunshu, Liu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908708/ https://www.ncbi.nlm.nih.gov/pubmed/33632224 http://dx.doi.org/10.1186/s12935-021-01842-x |
Ejemplares similares
-
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
por: Chen, Jihui, et al.
Publicado: (2021) -
Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer
por: Bai, Fang, et al.
Publicado: (2018) -
Characterization of Zebrafish Abcc4 as an Efflux Transporter of Organochlorine Pesticides
por: Lu, Xing, et al.
Publicado: (2014) -
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
por: Qin, Yiyang, et al.
Publicado: (2017) -
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
por: Henderson, Michelle J., et al.
Publicado: (2011)